Delivery Order SPE2DB22D2206-SPE2DB22FEF30
Award Date 8/8/22
Potential Completion Date 8/29/22
Potential Value $159K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The order, valued at $27,859.78, is for the supply of 28-count capsules of the pharmaceutical Revlimid 10 mg. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is one of multiple awards to Amerisourcebergen Drug Corp under an Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 100 capsules of the pharmaceutical product Revlimid 10 mg, with a potential value of $107,912.38. The delivery order has a completion date of February 27, 2023 and was awarded on February 3, 2023. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp is a for-profit...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 10 mg capsules of the drug Revlimid, valued at $49,926.80. The order has a firm fixed price and an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $56,490.52 firm-fixed-price contract is for the delivery of Revlimid 10 mg capsules and has an ultimate completion date of January 22, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Revlimid 10 mg capsules. The contract has a firm fixed price of $178,310.12 and a period of performance through August 8, 2024. The award is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for delivering a wide range...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,560 units of REVLIMID 10 MG CAPSULE 100S. The order, valued at $107,912.38, has a completion date of May 3, 2023. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order was not...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for $49,926.80. The order is for REVLIMID 10 MG CAPSULE 28S, a pharmaceutical product. The contract has an ultimate completion date of October 9, 2024 and is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REVLIMID 10 MG CAPSULE 100S. The order has a potential value of $158,419.32 and a completion date of February 5, 2024. No set-aside was used for this award. AmerisourceBergen Drug Corp is a prime contractor that provides pharmaceutical products and distribution services to support DLA Troop Support Medical facilities. The company...
- The Defense Logistics Agency awarded a delivery order valued at $12,329.16 to AmerisourceBergen Drug Corp for the supply of Revlimid 5 mg capsules (28-count) under a Firm Fixed Price contract with an ultimate completion date of September 3, 2025. This non-set-aside award was competitively awarded and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $161,868 delivery order to Amerisourcebergen Drug Corporation for 100 capsules of the pharmaceutical Revlimid 10 mg. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DOD customers. Amerisourcebergen will deliver the Revlimid capsules to a customer located in Conshohocken, Pennsylvania by July 13, 2023. Pricing for this firm fixed price order was pre-established under the terms of the...